Studies and Publications

Featured Study

4Life Transfer Factor is clinically proven to activate the immune system within two hours. Learn more.

4Life Transfer Factor Research

  • Peer-reviewed publications Safety assessment of long-term use of 4Life Transfer Factor using a variety of studies recommended by regulatory authorities. Learn more.
  • Beneficial impact of various compositions of transfer factors on the immune system.* Learn more.
  • Positive effects of cow colostrum and egg-derived transfer factors Part 1: Non-specific immunomodulation.* Learn more.
  • Positive effects of cow colostrum and egg-derived transfer factors Part 2: Antigen-specific immunomodulation.* Learn more.
  • Development of an immunological method to evaluate the efficacy of 4Life Transfer Factor against health threats.* Learn more.
  • Laboratory study reveals that Transfer Factor has the ability to calm down an overactive immune system. Learn more.

  • The immunomodulatory properties of Transfer Factor on enriched natural killer cells. Learn more.
  • 4Life Transfer Factor is clinically proven to activate the immune system in 2 hours. Learn more.
  • Third-party studies Safety assessment of a single oral high-dose of 4Life Transfer Factor. Learn more.
  • 4Life Transfer Factor is clinically proven to activate the immune system within two hours. Learn more.
  • Measuring how much 4Life Transfer Factor® Chewable Tri-Factor® formula is safe for consumption.* Learn more.
  • 4Life Transfer Factor suppresses an overactive immune response.* Learn more.

  • In-house studies Pilot study to assess the effectiveness of a user-friendly instrument in quantifying IgA in human saliva. Learn more.
  • Pilot study to obtain a normal range of salivary IgA by using a new, user-friendly instrument for humans. Learn more.
  • How 4Life Transfer Factor can modulate the immune system and Helper T Cell activity. Learn more.
  • Salivary IgA in healthy adults is increased by 4Life Transfer Factor. Learn more.
  • Method development for the analysis of pbmc-mediated killing of k562 cells by bovine colostrum*. Learn more.